Blood Clot Medication Eliquis Recalled Due to Mislabeling of Bottles

At least one bottle has been found to show the wrong dosage

Blood Clot Medication Eliquis Recalled Due to Mislabeling of Bottles
Image: FDA
June 15, 2017

Pharmacy company Bristol-Myers Squibb is recalling one lot of blood clot medication Eliquis tablets due to a mislabeling issue.

At least one bottle labeled as containing 5 mg of the medication actually contained 2.5 mg tablets.

The affected lot number of Eliquis 5 mg tablets is HN0063. It was distributed to wholesalers and retail pharmacies across the U.S. in February 2017. The 5 mg tablets are pink, oval, biconvex, and coated in film, and they include 894 debossed on one side and 5 on the other. In contrast, the 2.5 mg tablets are yellow, round, biconvex, and coated in film with 893 debossed on one side and on the other.

Consumers in possession of the recalled product should contact their physician as well as the Bristol-Myers Squibb Customer Information Center. Do not stop taking the medication without discussing it with your doctor. To date, no injuries or illnesses have been reported in connection with this incident.

For more information, consumers can reach the Bristol-Myers Squibb Customer Information Center at (800) 332-2056.